Cannabis use is associated with lower retention in methadone maintenance treatment, but not among schizophrenic- and other chronically psychotic patients.

Volkov, Ilan; Schreiber, Shaul; Adelson, Miriam; Shoshan, Stacy; Peles, Einat

Volkov, Ilan; Schreiber, Shaul; Adelson, Miriam; Shoshan, Stacy; Peles, Einat.

Affiliation

Volkov I; Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Schreiber S; Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Adelson M; Dr. Miriam & Sheldon G. Adelson Clinic for Drug Abuse, Treatment & Research, Tel-Aviv, Israel.
Shoshan S; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Peles E; Sagol School of Neuroscience, Tel Aviv University, Tel-Aviv, Israel.

J Addict Dis ; 40(2): 183-191, 2022.

Article in En | MEDLINE | ID: mdl-34379049

Subject(s)

Cannabis; Hallucinogens; Marijuana Abuse; Mental Disorders; Psychotic Disorders; Schizophrenia; Cannabis/adverse effects; Humans; Marijuana Abuse/complications; Marijuana Abuse/epidemiology; Mental Disorders/drug therapy; Methadone/therapeutic use; Opiate Substitution Treatment; Psychotic Disorders/drug therapy; Schizophrenia/drug therapy; Schizophrenia/epidemiology

Key words

Schizophrenia/psychosis; cannabis; methadone maintenance treatment; retention; survival

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Psychotic Disorders / Schizophrenia / Cannabis / Marijuana Abuse / Hallucinogens / Mental Disorders Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Language: En Journal: J Addict Dis Year: 2022 Type: Article Affiliation country: Israel

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google